|
Volumn 1, Issue 2, 2006, Pages 267-278
|
Autologous human-derived bone marrow cells exposed to a novel TGF-beta1 fusion protein for the treatment of critically sized tibial defect.
a a a a a a a |
Author keywords
[No Author keywords available]
|
Indexed keywords
HYBRID PROTEIN;
TRANSFORMING GROWTH FACTOR BETA1;
AGED;
ARTICLE;
AUTOTRANSPLANTATION;
BONE MARROW CELL;
BONE MARROW TRANSPLANTATION;
CASE REPORT;
CELL CULTURE;
CULTURE TECHNIQUE;
GENETICS;
HUMAN;
MALE;
METHODOLOGY;
TIBIA FRACTURE;
AGED;
BONE MARROW CELLS;
BONE MARROW TRANSPLANTATION;
CELL CULTURE TECHNIQUES;
CELLS, CULTURED;
HUMANS;
MALE;
RECOMBINANT FUSION PROTEINS;
TIBIAL FRACTURES;
TRANSFORMING GROWTH FACTOR BETA1;
TRANSPLANTATION, AUTOLOGOUS;
|
EID: 34249649671
PISSN: None
EISSN: 1746076X
Source Type: Journal
DOI: 10.2217/17460751.1.2.267 Document Type: Article |
Times cited : (13)
|
References (0)
|